中商官网
研究报告
立方制药（003020）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2012 | 733000000.0000 | 37929600.0000 | 39943300.0000 | 32842300.0000 | 359000000.0000 | 217000000.0000 | 142000000.0000 |
| 2013 | 878000000.0000 | 50256100.0000 | 54527200.0000 | 44814800.0000 | 446000000.0000 | 269000000.0000 | 177000000.0000 |
| 2014 | 962000000.0000 | 58335100.0000 | 63838000.0000 | 51853700.0000 | 476000000.0000 | 260000000.0000 | 216000000.0000 |
| 2016 | 1028000000.0000 | 75137600.0000 | 81170200.0000 | 67462500.0000 | 548000000.0000 | 250000000.0000 | 298000000.0000 |
| 2017 | 1167000000.0000 | 89955400.0000 | 91472000.0000 | 76819500.0000 | 613000000.0000 | 251000000.0000 | 362000000.0000 |
| 2018 | 1425000000.0000 | 108000000.0000 | 108000000.0000 | 91664100.0000 | 771000000.0000 | 265000000.0000 | 506000000.0000 |
| 2019 | 1650000000.0000 | 119000000.0000 | 122000000.0000 | 105000000.0000 | 890000000.0000 | 300000000.0000 | 590000000.0000 |
| 2020 | 1894000000.0000 | 157000000.0000 | 157000000.0000 | 135000000.0000 | 1536000000.0000 | 362000000.0000 | 1174000000.0000 |
| 2021 | 2273000000.0000 | 192000000.0000 | 195000000.0000 | 172000000.0000 | 1674000000.0000 | 371000000.0000 | 1304000000.0000 |
| 2022 | 2579000000.0000 | 240000000.0000 | 240000000.0000 | 209000000.0000 | 2121000000.0000 | 642000000.0000 | 1480000000.0000 |
| 2023 | 1901000000.0000 | 255000000.0000 | 257000000.0000 | 234000000.0000 | 2484000000.0000 | 610000000.0000 | 1873000000.0000 |
| 2024 | 1518000000.0000 | 178000000.0000 | 172000000.0000 | 152000000.0000 | 2586000000.0000 | 673000000.0000 | 1913000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2012 | 5.18 | 5.45 | 11.13 | 30.1500 | 8.1600 | 11.08 | 2.04 |
| 2013 | 5.81 | 6.21 | 12.23 | 29.5500 | 7.4700 | 10.49 | 1.97 |
| 2014 | 6.03 | 6.64 | 13.41 | 27.2200 | 5.9900 | 10.59 | 2.02 |
| 2016 | 7.30 | 7.90 | 14.81 | 25.0400 | 5.4200 | 12.73 | 1.88 |
| 2017 | 7.28 | 7.84 | 14.92 | 23.6000 | 5.8500 | 10.09 | 1.90 |
| 2018 | 6.67 | 7.58 | 14.01 | 22.3200 | 6.1500 | 7.99 | 1.85 |
| 2019 | 6.55 | 7.39 | 13.71 | 19.3100 | 6.5100 | 7.55 | 1.85 |
| 2020 | 7.76 | 8.29 | 10.22 | 21.1400 | 6.7600 | 8.12 | 1.23 |
| 2021 | 7.61 | 8.58 | 11.65 | 13.9700 | 7.1400 | 8.78 | 1.36 |
| 2022 | 7.68 | 9.31 | 11.32 | 15.1300 | 5.8700 | 8.55 | 1.22 |
| 2023 | 10.89 | 13.52 | 10.35 | 14.4000 | 3.0500 | 6.56 | 0.77 |
| 2024 | 9.62 | 11.33 | 6.65 | 9.3300 | 2.0200 | 4.84 | 0.59 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2012 | 60.45 | 39.55 | 1.1900 | 0.5800 |
| 2013 | 60.31 | 39.69 | 1.1500 | 0.5800 |
| 2014 | 54.62 | 45.38 | 1.2300 | 0.5800 |
| 2016 | 45.62 | 54.38 | 1.5800 | 0.7900 |
| 2017 | 40.95 | 59.05 | 1.9000 | 1.1200 |
| 2018 | 34.37 | 65.63 | 2.4000 | 1.5700 |
| 2019 | 33.71 | 66.29 | 2.4700 | 1.7500 |
| 2020 | 23.57 | 76.43 | 3.7700 | 3.0800 |
| 2021 | 22.16 | 77.90 | 3.7200 | 2.9800 |
| 2022 | 30.27 | 69.78 | 2.3300 | 1.6100 |
| 2023 | 24.56 | 75.40 | 2.1200 | 1.6200 |
| 2024 | 26.02 | 73.98 | 2.0400 | 1.5800 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2012 | 695000000.0000 | 67264200.0000 | 17530900.0000 | 2388700.0000 |
| 2013 | 827000000.0000 | 87129400.0000 | 21243400.0000 | 4228700.0000 |
| 2014 | 904000000.0000 | 85665800.0000 | 23498900.0000 | 4055200.0000 |
| 2016 | 953000000.0000 | 71389100.0000 | 22440600.0000 | 2501400.0000 |
| 2017 | 1082000000.0000 | 119000000.0000 | 25335400.0000 | 3147300.0000 |
| 2018 | 1330000000.0000 | 259000000.0000 | 35681400.0000 | 2557600.0000 |
| 2019 | 1542000000.0000 | 328000000.0000 | 34129800.0000 | 1041900.0000 |
| 2020 | 1747000000.0000 | 394000000.0000 | 39030700.0000 | 732400.0000 |
| 2021 | 2100000000.0000 | 605000000.0000 | 44861700.0000 | 1540500.0000 |
| 2022 | 2381000000.0000 | 616000000.0000 | 59140000.0000 | 480300.0000 |
| 2023 | 1694000000.0000 | 598000000.0000 | 61957300.0000 | 1113800.0000 |
| 2024 | 1372000000.0000 | 692000000.0000 | 81563600.0000 | 1915000.0000 |